Skip to content

Clinical trials

Myeloproliferative Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Australia Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20101
20111
20122
20132
20143
20153
20181
20192
20202
20214
20221
20231
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting9
Active, not recruiting6
Terminated5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group5
Incyte Corporation5
Celgene3
CTI BioPharma2
Novartis Pharmaceuticals2
Sierra Oncology LLC - a GSK company2
Ariad Pharmaceuticals1
Cogent Biosciences, Inc.1
Damora Therapeutics1
Disc Medicine, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders33
Primary Myelofibrosis19
Hematologic Diseases10
Thrombocythemia, Essential10
Polycythemia Vera9
Bone Marrow Diseases8
Myelodysplastic Syndromes8
Leukemia6
Anemia5
Leukemia, Myelomonocytic, Chronic5

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.